Established in 2006, IFL is a health economics consultancy headquartered in Hong Kong. With a presence across Asia, IFL works with clients to identify highest-value opportunities and develop the most effective strategy to take a pharmaceutical or medical device product from registration to reimbursement. IFL’s team is comprised of consultants with country-specific knowledge of pricing and reimbursement systems in Asia working alongside seasoned specialists with years of industry and functional experience. Our mission is to help our clients make distinctive inroads in their pricing and reimbursement strategy in Asia using an evidence-based approach and to continue to build a local team of experts who understand Asian healthcare markets and can effectively communicate with clients. INSPIRED BY CLIENT VALUES IFL’s team works with a wide range of clients including multinational and local pharmaceutical and medical technology companies. We are proud of our clients and what they think of us. We build long lasting relationships with them, responding and anticipating their needs. HEALTH ECONOMICS AND OUTCOMES RESEARCH PRICING AND MARKET ACCESS STRATEGY QUALITY OF LIFE ASSESSMENT HEALTH POLICY ANALYSIS STRATEGY & BUSINESS PLANNING,IFL works with clients to develop responsive and long-term pricing and market access strategies. LOCALIZED CLINICAL & ECONOMIC VALUE, Our Advanced Data & Analytics team turn local data into evidence-based insights & results. INTEGRATING SALES, MEDICAL & MARKETING,understanding that simply increasing the number of sales reps no longer correlates to increased sales. We supply our clients with the tools they need to identify highest-value opportunities and build selling muscle. IFL offers a wide range of training programs: Introduction to Health Economics-Health Technology Assessment as a Practical Tool: How to Maximize Investment. Advanced Techniques in Pharmacoeconomics.Custom tailored courses designed for clients’ specific needs